HETLIOZ LQ (TASIMELTEON) Trademark

Trademark Overview


On Thursday, October 29, 2020, a trademark application was filed for HETLIOZ LQ (TASIMELTEON) with the United States Patent and Trademark Office. The USPTO has given the HETLIOZ LQ (TASIMELTEON) trademark a serial number of 90288318. The federal status of this trademark filing is REGISTERED as of Tuesday, August 23, 2022. This trademark is owned by Vanda Pharmaceuticals Inc.. The HETLIOZ LQ (TASIMELTEON) trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhythm, and diseases and disorders having a circadian rhythm manifestation
hetlioz lq (tasimelteon)

General Information


Serial Number90288318
Word MarkHETLIOZ LQ (TASIMELTEON)
Filing DateThursday, October 29, 2020
Status700 - REGISTERED
Status DateTuesday, August 23, 2022
Registration Number6828606
Registration DateTuesday, August 23, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements


Description of MarkThe mark consists of the literal elements "Hetlioz LQ" in sans serif font above the literal element "(tasimelteon)", with a series of eleven circles of increasing diameter in an arc from the H to the open parenthesis.
Goods and ServicesPharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhythm, and diseases and disorders having a circadian rhythm manifestation
Disclaimer with Predetermined Text"TASIMELTEON"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2020
Primary Code005
First Use Anywhere DateFriday, August 28, 2020
First Use In Commerce DateTuesday, December 1, 2020

Trademark Owner History


Party NameVanda Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Trademark Events


Event DateEvent Description
Tuesday, August 23, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 23, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, July 21, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 20, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, June 17, 2022USE AMENDMENT FILED
Monday, June 27, 2022SOU EXTENSION 2 GRANTED
Friday, June 17, 2022SOU EXTENSION 2 FILED
Monday, June 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 17, 2022TEAS EXTENSION RECEIVED
Friday, June 17, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, December 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 27, 2021SOU EXTENSION 1 GRANTED
Monday, December 27, 2021SOU EXTENSION 1 FILED
Monday, December 27, 2021TEAS EXTENSION RECEIVED
Tuesday, July 6, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 5, 2021EXAMINER'S AMENDMENT ENTERED
Monday, April 5, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 5, 2021EXAMINERS AMENDMENT E-MAILED
Monday, April 5, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 30, 2021ASSIGNED TO EXAMINER
Wednesday, December 23, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 2, 2020NEW APPLICATION ENTERED IN TRAM